FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure - Top-Institutions - MDSpire

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

  • By

  • Kathryn Wighton

  • June 2, 2026

Share

Top Institutions in Infectious Disease

Brief introduction explaining scope and methodology.

  • #1

    University of Virginia School of Medicine
    University of Virginia School of Medicine

    Charlottesville, Virginia

    Key Differentiators

    • Infectious Disease

  • #2

    Platform Adaptative Trial of Novel Antivirals for Early Treatment of COVID-19 in the Community (PANORAMIC)
    Platform Adaptative Trial of Novel Antivirals for Early Treatment of COVID-19 in the Community (PANORAMIC)

    N/A, N/A

    Key Differentiators

    • Clinical Trials

  • #3

    UK National Health Service (NHS)
    UK National Health Service (NHS)

    London, England

    Key Differentiators

    • Healthcare Administration

  • #4

    National Institute for Health and Care Excellence (NICE)
    National Institute for Health and Care Excellence (NICE)

    London, England

    Key Differentiators

    • Health Economics

  • #5

    Tokushukai Medical Group
    Tokushukai Medical Group

    Tokyo, Japan

    Key Differentiators

    • Healthcare Delivery

Original Source(s)

FDA Approves Ensitrelvir to Prevent COVID-19 After Exposure

  • by Kathryn Wighton

  • June 2, 2026

Related Content

CDC says containing the spread of Ebola is top priority

Decision Aids for Vaccination in an Era of Medical Freedom

Dynamic hyperinflammatory response assessment using HIC scores in COVID-19: application to a large series of patients receiving anakinra